Motilin and ghrelin receptor agonists are prokinetic drug candidates for gastroparesis, with ghrelin's dual appetite + motility effects offering unique therapeutic advantages over pure prokinetics.
Key findingMotilin and ghrelin receptor agonists are prokinetic drug candidates for gastroparesis, with ghrelin's dual appetite + motility effects offering uniqu
What the researchers found
Motilin and ghrelin receptor agonists are prokinetic drug candidates for gastroparesis, with ghrelin's dual appetite + motility effects offering unique therapeutic advantages over pure prokinetics.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2009.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Motilin and ghrelin as prokinetic drug targets.
Pharmacology & therapeutics, 123(2), 207-23
Citation
De Smet, Betty; Mitselos, Anna; Depoortere, Inge. (2009). Motilin and ghrelin as prokinetic drug targets.. Pharmacology & therapeutics, 123(2), 207-23. https://doi.org/10.1016/j.pharmthera.2009.04.004